Ceva Animal Health (Ceva), the leading French animal health company and the 5th largest global player, present in 110 countries, announces a change in its Executive Committee with the appointment of Christophe Bailet as Group Chief Financial Officer.

Christophe Bailet joined Ceva on October 1, 2024. He began his career as a financial analyst at Société Générale and then spent 20 years at Saint-Gobain in various senior financial positions, particularly in international roles. He subsequently served as CFO for the Benvic and Kem One groups, both LBO companies and leaders in the vinyl sector.

Christophe Bailet holds an MBA from ESSEC Business School and he graduated from the École Normale Supérieure in Letters and Human Sciences. He brings to Ceva extensive international experience in finance, with a particular expertise in managing LBO operations and corporate refinancing.

In his new role, Christophe Bailet will be primarily responsible for overseeing the group’s next refinancing cycle and strengthening financial performance to meet Ceva’s ambitious goals.

He succeeds Alain de Woillemont, who held the position for 10 years and who will continue to provide his expertise throughout the next refinancing phase. Ceva’s leadership expresses its deep gratitude to Alain de Woillemont for his exceptional professionalism and dedication, whose diligent work enabled the company to refinance its activities multiple times under particularly favorable conditions.

Christophe Bailet, newly appointed Chief Financial Officer of Ceva Animal Health, stated: “Joining Ceva at this pivotal moment in its evolution is a tremendous opportunity. Ceva is both a leader in animal health innovation and a rapidly expanding global company. I am honored to bring my expertise to support this ambitious growth and to lead the financial team in implementing the next strategic objectives. Ceva has significant potential to address the current and future challenges of the industry, and I am excited to contribute to this journey.”